A

ABL Bio Inc
KOSDAQ:298380

Watchlist Manager
ABL Bio Inc
KOSDAQ:298380
Watchlist
Price: 35 600 KRW -0.56%
Market Cap: 1.7T KRW

Intrinsic Value

The intrinsic value of one ABL Bio Inc stock under the Base Case scenario is 9 717.33 KRW. Compared to the current market price of 35 600 KRW, ABL Bio Inc is Overvalued by 73%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
9 717.33 KRW
Overvaluation 73%
Intrinsic Value
Price
A
Worst Case
Base Case
Best Case

Valuation History
ABL Bio Inc

ABL Bio Inc
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for ABL Bio Inc cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

ABL Bio Inc
KOSDAQ:298380
KR
Biotechnology
Market Cap
1.7T KRW
IPO
Dec 19, 2018
KR
Biotechnology
Market Cap
1.7T KRW
IPO
Dec 19, 2018
Price
â‚©false
EPS
â‚©false
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ABL Bio Inc?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about ABL Bio Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
ABL Bio Inc

Current Assets 144.2B
Cash & Short-Term Investments 140.7B
Receivables 1.2B
Other Current Assets 2.3B
Non-Current Assets 87.8B
PP&E 85.4B
Intangibles 2.4B
Other Non-Current Assets 28m
Efficiency

Free Cash Flow Analysis
ABL Bio Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
ABL Bio Inc

Revenue
33.4B KRW
Operating Expenses
-92.8B KRW
Operating Income
-59.4B KRW
Other Expenses
3.8B KRW
Net Income
-55.5B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

ABL Bio Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
ROIC is Increasing
ROE is Increasing
Negative Revenue Growth Forecast
24/100
Profitability
Score

ABL Bio Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

ABL Bio Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Negative Net Debt
Low D/E
67/100
Solvency
Score

ABL Bio Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
ABL Bio Inc

Wall Street analysts forecast ABL Bio Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABL Bio Inc is 52 275 KRW with a low forecast of 40 400 KRW and a high forecast of 63 000 KRW.

Lowest
Price Target
40 400 KRW
13% Upside
Average
Price Target
52 275 KRW
47% Upside
Highest
Price Target
63 000 KRW
77% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

ABL Bio Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ABL Bio Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one ABL Bio Inc stock?

The intrinsic value of one ABL Bio Inc stock under the Base Case scenario is 9 717.33 KRW.

Is ABL Bio Inc stock undervalued or overvalued?

Compared to the current market price of 35 600 KRW, ABL Bio Inc is Overvalued by 73%.

Back to Top